Join us at DDW25 to explore how ClearNote Health is harnessing the power of the epigenome to drive early pancreatic cancer detection and transform patient outcomes.
📍 Visit us at booth #5525 to learn more about the @Avantect Pancreatic Cancer Test – a simple, cell-free DNA blood test that aims to enable earlier diagnosis and improve patient outcomes.
Plus, don’t miss the opportunity to connect with our CSO, Dr. Samuel Levy, to discuss the latest in liquid biopsy innovation, biomarker discovery, and new avenues for collaboration.
We look forward to seeing you there!